NCR1 and cancer: The downregulation of NCR1 on NK cells, a phenotype prevalent in cancer,84,85,86,87,88,89,90,91 and its association with impaired cytotoxicity and increased IFNγ production,92,93 likely reflects a strategic adaptation to T. gondii infection, prioritizing tissue integrity and control of inflammation over cytotoxic actions.